January 30, 2019
A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response
Read More
January 30, 2019
High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3
Read More
December 10, 2018
Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma
Read More
December 10, 2018
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Read More
X